These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Patient preference for oral chemotherapy]. Schöffski P Krankenpfl J; 2002; 40(1-2):40-1. PubMed ID: 12035416 [No Abstract] [Full Text] [Related]
3. Capecitabine and tegafur + uracil: new preparations. Metastatic colorectal cancer: two oral fluorouracil precursors, few advantages. Prescrire Int; 2002 Apr; 11(58):44-7. PubMed ID: 11987311 [TBL] [Abstract][Full Text] [Related]
4. Randomized crossover trial of intravenous 5-FU versus oral UFT both modulated by leucovorin: a one-centre experience. Lima AP; del Giglio A Eur J Cancer Care (Engl); 2005 May; 14(2):151-4. PubMed ID: 15842464 [TBL] [Abstract][Full Text] [Related]
5. [Intravenous continuous infusion of fluorouracil for treatment of metastatic colorectal cancer]. Hosokawa A Nihon Rinsho; 2003 Sep; 61 Suppl 7():352-5. PubMed ID: 14574911 [No Abstract] [Full Text] [Related]
6. Protracted treatment with tegafur and low dose oral leucovorin in patients with advanced colorectal carcinoma. Rubiales AS; del Valle ML Cancer; 1999 Apr; 85(8):1866-7. PubMed ID: 10223583 [No Abstract] [Full Text] [Related]
7. Health-related quality of life in patients with colorectal cancer who receive oral uracil and tegafur plus leucovorin. Tsunoda A; Nakao K; Watanabe M; Matsui N; Tsunoda Y Jpn J Clin Oncol; 2010 May; 40(5):412-9. PubMed ID: 20085907 [TBL] [Abstract][Full Text] [Related]
8. Oral uracil and tegafur plus leucovorin compared with intravenous fluorouracil and leucovorin in stage II and III carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project Protocol C-06. Lembersky BC; Wieand HS; Petrelli NJ; O'Connell MJ; Colangelo LH; Smith RE; Seay TE; Giguere JK; Marshall ME; Jacobs AD; Colman LK; Soran A; Yothers G; Wolmark N J Clin Oncol; 2006 May; 24(13):2059-64. PubMed ID: 16648506 [TBL] [Abstract][Full Text] [Related]
9. Randomised study of tegafur and oral leucovorin versus intravenous 5-fluorouracil and leucovorin in patients with advanced colorectal cancer. Nogué M; Salud A; Batiste-Alentorn E; Saigí E; Losa F; Cirera L; Méndez M; Campos JM; Galan A; Escudero P; Arcusa A; Manzano H; de Mendizábal EV; de Olaguer JP; Boleda M; Guasch I; Vicente P Eur J Cancer; 2005 Oct; 41(15):2241-9. PubMed ID: 16214045 [TBL] [Abstract][Full Text] [Related]
10. Chemotherapy of metastatic colorectal cancer: fluorouracil plus folinic acid and irinotecan or oxaliplatin. Prescrire Int; 2005 Dec; 14(80):230-3. PubMed ID: 16400749 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the efficacy, toxicity, and pharmacokinetics of a uracil/tegafur (UFT) plus oral leucovorin (LV) regimen between Japanese and American patients with advanced colorectal cancer: joint United States and Japan study of UFT/LV. Shirao K; Hoff PM; Ohtsu A; Loehrer PJ; Hyodo I; Wadler S; Wadleigh RG; O'Dwyer PJ; Muro K; Yamada Y; Boku N; Nagashima F; Abbruzzese JL J Clin Oncol; 2004 Sep; 22(17):3466-74. PubMed ID: 15277535 [TBL] [Abstract][Full Text] [Related]
12. Oral tegafur-uracil plus folinic acid versus intravenous 5-fluorouracil plus folinic acid as adjuvant chemotherapy of colon cancer. Kim DJ; Kim TI; Suh JH; Cho YS; Shin SK; Kang JK; Kim NK; Kim WH Yonsei Med J; 2003 Aug; 44(4):665-75. PubMed ID: 12950123 [TBL] [Abstract][Full Text] [Related]
13. [5-FU pharmacokinetic study of 5-FU hepato-arterial infusion with oral UFT]. Maruyama M; Ebuchi M; Nagahama T; Takashima I; Hasegawa K; Ochiai T; Natui S Gan To Kagaku Ryoho; 2002 Nov; 29(12):2109-11. PubMed ID: 12484014 [TBL] [Abstract][Full Text] [Related]
14. [Feasibility of weekday-on/weekend-off oral UFT/Leucovorin schedule as postoperative adjuvant chemotherapy for colorectal cancer]. Sadahiro S; Suzuki T; Maeda Y; Makuuchi H; Murayama C Gan To Kagaku Ryoho; 2006 Mar; 33(3):333-6. PubMed ID: 16531713 [TBL] [Abstract][Full Text] [Related]
15. Retrospective study of S-1 versus tegafur/uracil and oral leucovorin in patients with metastatic colorectal cancer. Shibahara K; Yamamoto M; Kakeji Y; Sakata H; Maehara Y Anticancer Res; 2008; 28(3B):1779-83. PubMed ID: 18630459 [TBL] [Abstract][Full Text] [Related]
16. A phase II study of oral UFT and leucovorin concurrently with pelvic irradiation as neoadjuvant chemoradiation for rectal cancer. Kundel Y; Brenner B; Symon Z; Oberman B; Sadezki S; Koller M; Catane R; Pfeffer R Anticancer Res; 2007; 27(4C):2877-80. PubMed ID: 17695464 [TBL] [Abstract][Full Text] [Related]
17. Biweekly oxaliplatin plus 1-day infusional fluorouracil/leucovorin followed by metronomic chemotherapy with tegafur/uracil in pretreated metastatic colorectal cancer. Lin PC; Chen WS; Chao TC; Yang SH; Tiu CM; Liu JH Cancer Chemother Pharmacol; 2007 Aug; 60(3):351-6. PubMed ID: 17111120 [TBL] [Abstract][Full Text] [Related]
18. [Progress in adjuvant therapy for colorectal cancer]. Kohnoe S; Kakeji Y; Maehara Y Gan To Kagaku Ryoho; 2002 Dec; 29(13):2488-97. PubMed ID: 12506471 [TBL] [Abstract][Full Text] [Related]
19. Quality of life in operable colon cancer patients receiving oral compared with intravenous chemotherapy: results from National Surgical Adjuvant Breast and Bowel Project Trial C-06. Kopec JA; Yothers G; Ganz PA; Land SR; Cecchini RS; Wieand HS; Lembersky BC; Wolmark N J Clin Oncol; 2007 Feb; 25(4):424-30. PubMed ID: 17264338 [TBL] [Abstract][Full Text] [Related]
20. Oral uracil and tegafur compared with classic cyclophosphamide, methotrexate, fluorouracil as postoperative chemotherapy in patients with node-negative, high-risk breast cancer: National Surgical Adjuvant Study for Breast Cancer 01 Trial. Watanabe T; Sano M; Takashima S; Kitaya T; Tokuda Y; Yoshimoto M; Kohno N; Nakagami K; Iwata H; Shimozuma K; Sonoo H; Tsuda H; Sakamoto G; Ohashi Y J Clin Oncol; 2009 Mar; 27(9):1368-74. PubMed ID: 19204202 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]